Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone in Acute Decompensated Heart Failure (REDEFINE-HF)
NCT06008197Phase 3Recruiting
- Sponsor
- CPC Clinical Research
- Start
- Jan 2024
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 26
01
Overview
A Phase 3 trial of finerenone in heart failure (HF), sponsored by CPC Clinical Research. Started Jan 2024; status: recruiting.
02
Drugs
finerenone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06008197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06008197.